Skip to main content
. 2022 Apr 7;30(Suppl 1):88–608. doi: 10.1038/s41431-021-01026-1
ID SEX AGE AT DIAGNOSIS PHENOTYPE TREATMENT VARIANT 1 VARIANT 2 CURRENT SITUATION
1 Female 2 months DCM Pharmacological R4W A94T LVEF 46%
2 Male 2 weeks DCM Pharmacological R161W G27D Exitus
3 Female 1.5 months DCM Pharmacological R161W G27D Transplanted
4 Female 2 weeks DCM PharmacologicalTransplant R242W D308N No transplant rejection
5 Female 65 years DCM > LVNC Short stature, kyphoscoliosis Pharmacological A256T M168V LVEF 20-27%
6 Female 9 years LVNC > DCM Pharmacological D308N LVEF 50%
7 Female 9 years LVNC > DCM Pharmacological D308N LVEF 58%
8 Female 1 month DCM > LVNC Ventricular assist device c.618C>T Transplant wait list